🔎 Trials Near Me

Beranda › Diabetes Tipe 1 › Texas

Uji klinis Diabetes Tipe 1 di Texas

16 studi untuk Diabetes Tipe 1 mencari peserta di lokasi di Texas.

Kota di Texas

Teks studi resmi (Bahasa Inggris)

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  • Driscoll Children's Hospital, Corpus Christi
Menerima pesertaFase 3
Usia 1 hingga 35 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07222332

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  • Baylor College of Medicine- Site Number : 8400057, Houston
Menerima pesertaFase 3
Usia 1 hingga 25 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07088068

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  • Texas Diabetes & Endocrinology, Austin
  • M3 Wake Research - Dallas, Dallas
  • Accurate Clinical Research, Inc, Humble
  • dan 2 lainnya
Menerima pesertaFase 1/2
Usia 12 hingga 35 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06783309

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

  • Baylor College of Medicine, Houston
Menerima pesertaFase 1/2
Usia 9 hingga 20 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07061574

A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

  • Baylor Scott and White Research Institute, Dallas
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT04786262

Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring

  • Texas A&M University, College Station
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07254364

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

  • Texas Diabetes & Endocrinology, Austin
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07599982

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

  • Children's Medical Centre Dallas, Dallas
  • Cook Children's Medical Center, Fort Worth
  • Texas Children's Hospital - Clinical Care Center - Pediatric Renal Clinic, Houston
  • dan 1 lainnya
Menerima pesertaFase 2
Usia 5 hingga 40 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT07187531

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

  • Baylor College of Medicine, Houston
Menerima pesertaFase 2
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT07224321

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  • Baylor College of Medicine, Houston
Menerima peserta
Usia 14 hingga 75 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT07579702

Kidney Precision Medicine Project

  • University of Texas at Southwestern, Dallas
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Apr 2026 · NCT04334707

Registry for Stage 2 Type 1 Diabetes

  • Texas Diabetes & Endocrinology - Austin - North Mopac Expressway- Site Number : 8400040, Austin
  • University of Texas - Southwestern Medical Center- Site Number : 8400003, Dallas
  • Cook Children's- Site Number : 8400038, Fort Worth
  • dan 1 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06481904

Immune Function and the Progression to T1D

  • Baylor College of Medicine, Center for Research Advancement - Texas Children's Hospital, Houston
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 hingga 100 · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT05899439

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • University of Texas Southwestern, Dallas
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT06217302

TrialNet Pathway to Prevention of T1D

  • University of Texas Medical Center at Dallas, Dallas
  • Baylor College of Medicine, Houston
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 45 · Semua jenis kelamin · Diperbarui 1 Jul 2025 · NCT00097292

Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

  • WoundCentrics Wound Care & Hyperbarics -Corpus Christi - Shoreline, Corpus Christi
  • Woundcentrics Wound Care Center At Corpus Christi South, Corpus Christi
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 12 Jun 2025 · NCT06810726

Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.